Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris

Inclusion Criteria: * Male and female subjects of any race and at least 12 years of age. * Female subjects of childbearing potential must have a negative urine pregnancy test at Baseline and practice a reliable method of contraception throughout the study. * Truncal acne IGA score of 3. * Able to understand the requirements of study and sign Informed Consent/HIPAA forms. Exclusion Criteria: * Female subjects who are pregnant , breast feeding or are of childbearing potential who are not willing to use a reliable method birth control. * Subjects who have an allergy or sensitivity to any component of the test medication. * Subjects who have not complied with the proper wash out periods for prohibited medications. * Evidence of recent drug or alcohol abuse. * Skin disease /disorder that might interfere with the diagnosis or evaluation of truncal acne. * Exposure to an investigational drug within 30 days of the Baseline visit. * Medical condition that contraindicates the subject's participation in the study. * History of poor cooperation, non-compliance with medical treatment or unreliability.